AAAAAA

   
Results: 1-17 |
Results: 17

Authors: Park, YK Chi, SG Unni, KK
Citation: Yk. Park et al., Absence of Bcl10 gene mutations in Ewing's sarcomas, ONCOL REP, 8(6), 2001, pp. 1333-1335

Authors: Park, YK Chi, SG Kim, YW Park, HR Unni, KK
Citation: Yk. Park et al., P53 mutations in Ewing's sarcoma, ONCOL REP, 8(3), 2001, pp. 533-537

Authors: Park, YK Cho, CH Chi, SG Han, CS Ushigome, S Unni, KK
Citation: Yk. Park et al., Low incidence of genetic alterations of the p16(CDKN2a) in clear cell chondrosarcoma, INT J ONCOL, 19(4), 2001, pp. 749-753

Authors: Park, YK Park, HR Chi, SG Ushigome, S Unni, KK
Citation: Yk. Park et al., Overexpression of p53 and absent genetic mutation in clear cell chondrosarcoma, INT J ONCOL, 19(2), 2001, pp. 353-357

Authors: Lee, MG Lee, KT Chi, SG Park, JH
Citation: Mg. Lee et al., Costunolide induces apoptosis by ROS-mediated mitochondrial permeability transition and cytochrome C release, BIOL PHAR B, 24(3), 2001, pp. 303-306

Authors: Ryu, BK Lee, MG Chi, SG Kim, YH Park, JH
Citation: Bk. Ryu et al., Increased expression of cFLIP(L) in colonic adeno carcinoma, J PATHOLOGY, 194(1), 2001, pp. 15-19

Authors: Byun, DS Lee, MG Chae, KS Ryu, BG Chi, SG
Citation: Ds. Byun et al., Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma, CANCER RES, 61(19), 2001, pp. 7034-7038

Authors: Lee, MG Kim, HY Byun, DS Lee, SJ Lee, CH Kim, JI Chang, SG Chi, SG
Citation: Mg. Lee et al., Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma, CANCER RES, 61(18), 2001, pp. 6688-6692

Authors: Kang, MJ Park, BJ Byun, DS Park, JI Kim, HJ Park, JH Chi, SG
Citation: Mj. Kang et al., Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma, CLIN CANC R, 6(5), 2000, pp. 1767-1771

Authors: Park, YK Park, HR Chi, SG Kim, CJ Sohn, KR Koh, JS Kim, CW Yang, WI Ro, JY Ahn, KW Joo, M Kim, YW Lee, J Yang, MH Unni, KK
Citation: Yk. Park et al., Overexpression of p53 and rare genetic mutation in mesenchymal chondrosarcoma, ONCOL REP, 7(5), 2000, pp. 1041-1047

Authors: Bae, DK Park, YK Chi, SG Lee, CW Unni, KK
Citation: Dk. Bae et al., Mutational alterations of the p16(CDKN2A) tumor suppressor gene have low incidence in mesenchymal chondrosarcoma, ONCOL RES, 12(1), 2000, pp. 5-10

Authors: Park, BJ Lee, SJ Kim, JI Lee, SJ Lee, CH Chang, SG Park, JH Chi, SG
Citation: Bj. Park et al., Frequent alteration of p63 expression in human primary bladder carcinomas, CANCER RES, 60(13), 2000, pp. 3370-3374

Authors: Park, BJ Park, JI Byun, DS Park, JH Chi, SG
Citation: Bj. Park et al., Mitogenic conversion of transforming growth factor-beta 1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer, CANCER RES, 60(11), 2000, pp. 3031-3038

Authors: Park, YK Chi, SG Kim, YW Park, HR Unni, KK
Citation: Yk. Park et al., Mutational alteration of the p16(CDKN2a) tumor suppressor gene is infrequent in Ewing's sarcoma, ONCOL REP, 6(6), 1999, pp. 1261-1266

Authors: Gumbiner, LM Gumerlock, PH Mack, PC Chi, SG White, RWD Mohler, JL Pretlow, TG Tricoli, JV
Citation: Lm. Gumbiner et al., Overexpression of cyclin D1 is rare in human prostate carcinoma, PROSTATE, 38(1), 1999, pp. 40-45

Authors: Chi, SG Chang, SG Lee, SJ Lee, CH Il Kim, J Park, JH
Citation: Sg. Chi et al., Elevated and biallelic expression of p73 is associated with progression ofhuman bladder cancer, CANCER RES, 59(12), 1999, pp. 2791-2793

Authors: Meyers, FJ Gumerlock, PH Chi, SG Borchers, H Deitch, AD White, RWD
Citation: Fj. Meyers et al., Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors, CANCER, 83(12), 1998, pp. 2534-2539
Risultati: 1-17 |